Oncology PracticeNeoadjuvant removal of DCIS helps identify HER2+ nonsurgical trial candidatesMay 8, 2019Breast Cancer
Oncology PracticeBioimpedance spectroscopy may better identify lymphedema progressionMay 7, 2019Breast CancerPatient & Survivor Care
Oncology PracticeInterplay of TP53, ESR2 may expand treatment options for some TNBCsMay 6, 2019Breast Cancer
Oncology PracticeOpioid management program reduced number of narcotics prescribed after breast surgeryMay 2, 2019Breast CancerPatient & Survivor Care
Oncology PracticeNovel CAR T, anti-PD-1 combo shows promise in MPDApril 16, 2019Immuno-oncologyBreast CancerLung Cancer
Oncology PracticeImmunotherapy overtaking breast cancer treatment landscapeApril 15, 2019Breast CancerImmuno-oncology
Oncology PracticeACP: Average-risk women under 50 can postpone mammogramApril 8, 2019Preventive CareBreast Cancer
Oncology PracticeFDA approves palbociclib for men with HR+/HER2- advanced breast cancerApril 4, 2019Breast Cancer
Oncology PracticeFDA proposes updates to mammography regulationsMarch 28, 2019Preventive CareBreast Cancer
Oncology PracticeAnastrozole/fulvestrant prolongs OS in metastatic ER+ breast cancerMarch 27, 2019Breast Cancer
Oncology PracticeBreast cancer survivors offer realistic strategies for easing cost burdenMarch 18, 2019Practice ManagementBreast CancerBusiness of Medicine
